Follow the サンバイオ株式会社 stock price and the full management transaction log of the company, a listed equity based in Japan. Shares are listed on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, サンバイオ株式会社 has recorded 19 reports. Market capitalisation: €79.7bn. The latest transaction was reported on 22 July 2026 (Holding update). Among the most active insiders: Nomura Securities Co.,Ltd.. The full history is accessible without an account.
19
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
SanBio Company es una empresa centrada en el sector de la salud y farmacéutico, dedicada al desarrollo de terapias innovadoras. Cotiza en el mercado XTKS.